Enzalutamide: A Novel Anti-androgen with Prolonged Survival Rate in CRPC Patients

E-ISSN： 1875-5607|13|10|1475-1486

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.13, Iss.10, 2013-08, pp. : 1475-1486

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Resistance of Enzalutamide in CRPC

Current Drug Targets, Vol. 19, Iss. 6, 2018-04 ,pp. : 613-620

Bentham Science Publishers

Access to resources Recommend Favorite

Is Prolonged QTc Sufficient to Predict Survival in Patients with Intracerebral Hemorrhage?

By Hjalmarsson Clara Bergfeldt Lennart

Annals of Noninvasive Electrocardiology, Vol. 19, Iss. 2, 2014-03 ,pp. : 205-206

Blackwell Publishing

Access to resources Recommend Favorite

Is Prolonged QTc Sufficient to Predict Survival in Patients with Intracerebral Hemorrhage?

By Koza Yavuzer

Annals of Noninvasive Electrocardiology, Vol. 19, Iss. 2, 2014-03 ,pp. : 203-204

Blackwell Publishing

Access to resources Recommend Favorite

Beta‐galactosidase deficiency: Studies of two patients with prolonged survival

American Journal of Medical Genetics, Vol. 5, Iss. 3, 1980-01 ,pp. : 235-245

John Wiley & Sons Inc

Access to resources Recommend Favorite

The use of antiandrogen therapy in refractory obsessive-compulsive male patients

By Casas M. Barcia D. Vallejo J. Turoacute n V. Salorio P. Ruiz E. Duro P. Tejero A.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 163-163

Elsevier

Access to resources Recommend Favorite